$23.53
-0.18[-0.76%]
At close: Apr 25
$23.53
0[0.00%]
After Hours: 4:00PM EDT
Exelixis
(NASDAQ:EXEL)Exelixis Stock (NASDAQ:EXEL), Analyst Ratings, Price Targets, Predictions
Exelixis Inc has a consensus price target of $28, established from looking at the 55 latest analyst ratings. The last 3 analyst ratings were released from Barclays, JMP Securities, and RBC Capital on April 11, 2024, April 10, 2024, and February 7, 2024. With an average price target of $26.67 between Barclays, JMP Securities, and RBC Capital, there's an implied 13.33% upside for Exelixis Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Barclays
JMP Securities
RBC Capital
Stifel
BTIG
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Exelixis
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/11/2024 | EXEL | Buy Now | Exelixis | $23.53 | 6.25% | Barclays | Peter Lawson | $25 → $25 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 04/10/2024 | EXEL | Buy Now | Exelixis | $23.53 | 14.75% | JMP Securities | Silvan Tuerkcan | → $27 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 02/07/2024 | EXEL | Buy Now | Exelixis | $23.53 | 19% | RBC Capital | Gregory Renza | $26 → $28 | Maintains | Outperform | Get Alert |
| 02/02/2024 | EXEL | Buy Now | Exelixis | $23.53 | 6.25% | Stifel | Stephen Willey | $23 → $25 | Maintains | Hold | Get Alert |
| 01/30/2024 | EXEL | Buy Now | Exelixis | $23.53 | 6.25% | Barclays | Peter Lawson | $24 → $25 | Maintains | Overweight | Get Alert |
| 12/19/2023 | EXEL | Buy Now | Exelixis | $23.53 | 14.75% | BTIG | Kaveri Pohlman | → $27 | Initiates | → Buy | Get Alert |
| 12/15/2023 | EXEL | Buy Now | Exelixis | $23.53 | 31.75% | Citigroup | David Lebowitz | → $31 | Initiates | → Buy | Get Alert |
| 12/14/2023 | EXEL | Buy Now | Exelixis | $23.53 | 14.75% | JMP Securities | Silvan Tuerkcan | → $27 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 12/13/2023 | EXEL | Buy Now | Exelixis | $23.53 | 10.5% | RBC Capital | Gregory Renza | → $26 | Reiterates | Outperform → Outperform | Get Alert |
| 11/13/2023 | EXEL | Buy Now | Exelixis | $23.53 | 14.75% | JMP Securities | Silvan Tuerkcan | → $27 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 11/02/2023 | EXEL | Buy Now | Exelixis | $23.53 | -2.25% | Morgan Stanley | Jefferson Harralson | $22 → $23 | Maintains | Equal-Weight | Get Alert |
| 10/11/2023 | EXEL | Buy Now | Exelixis | $23.53 | 27.5% | Guggenheim | Michael Schmidt | → $30 | Reiterates | Buy → Buy | Get Alert |
| 09/26/2023 | EXEL | Buy Now | Exelixis | $23.53 | 19% | HC Wainwright & Co. | Robert Burns | → $28 | Initiates | → Buy | Get Alert |
| 09/25/2023 | EXEL | Buy Now | Exelixis | $23.53 | 27.5% | Guggenheim | Michael Schmidt | $27 → $30 | Maintains | Buy | Get Alert |
| 09/13/2023 | EXEL | Buy Now | Exelixis | $23.53 | -2.25% | Stifel | Stephen Willey | → $23 | Reiterates | Hold → Hold | Get Alert |
| 09/13/2023 | EXEL | Buy Now | Exelixis | $23.53 | 36% | Truist Securities | Asthika Goonewardene | → $32 | Reiterates | Buy → Buy | Get Alert |
| 08/22/2023 | EXEL | Buy Now | Exelixis | $23.53 | 23.25% | Oppenheimer | Jay Olson | $25 → $29 | Maintains | Outperform | Get Alert |
| 08/22/2023 | EXEL | Buy Now | Exelixis | $23.53 | 14.75% | JMP Securities | Silvan Tuerkcan | $24 → $27 | Maintains | Outperform | Get Alert |
| 08/08/2023 | EXEL | Buy Now | Exelixis | $23.53 | -23.5% | SVB Leerink | Christopher Liu | → $18 | Initiates | → Market Perform | Get Alert |
FAQ
What is the target price for Exelixis (EXEL)?
The latest price target for Exelixis (NASDAQ: EXEL) was reported by Barclays on April 11, 2024. The analyst firm set a price target for $25.00 expecting EXEL to rise to within 12 months (a possible 6.25% upside). 29 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Exelixis (EXEL)?
The latest analyst rating for Exelixis (NASDAQ: EXEL) was provided by Barclays, and Exelixis downgraded their equal-weight rating.
When was the last upgrade for Exelixis (EXEL)?
There is no last upgrade for Exelixis.
When was the last downgrade for Exelixis (EXEL)?
The last downgrade for Exelixis Inc happened on April 11, 2024 when Barclays changed their price target from $25 to $25 for Exelixis Inc.
When is the next analyst rating going to be posted or updated for Exelixis (EXEL)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Exelixis, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Exelixis was filed on April 11, 2024 so you should expect the next rating to be made available sometime around April 11, 2025.
Is the Analyst Rating Exelixis (EXEL) correct?
While ratings are subjective and will change, the latest Exelixis (EXEL) rating was a downgraded with a price target of $25.00 to $25.00. The current price Exelixis (EXEL) is trading at is $23.53, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.